Ceftriaxone-associated gallbladder pseudolithiasis: report of one case.
Ceftriaxone is known to induce reversible precipitates in the gallbladders of adults and children. However, ceftriaxone-associated gallbladder pseudolithiasis in children is rarely reported in Taiwan. We report a case of 5-year-old boy with Salmonella gastroenteritis, who was treated with ceftriaxone due to multidrug resistance and severe course. Cholelithiasis developed five days after initiation of ceftriaxone therapy and completely resolved one month after the end of treatment. Pediatricians and radiologists must be aware of this complication to prevent anxiety and unnecessary cholecystectomy.
Wen
Hsiu-Huei
HH
Department of Pediatrics, Ten-Chan Hospital, Tao Yuan, Taiwan. service@tcmg.com.tw
Huang
Yao-Kang
YK
Zheng
Gui-Lin
GL
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D002443:Ceftriaxone / Q000009:adverse effects* / Q000627:therapeutic use; D002675:Child, Preschool; D002769:Cholelithiasis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D004751:Enteritis / Q000188:drug therapy / Q000209:etiology; D005704:Gallbladder / Q000000981:diagnostic imaging / Q000187:drug effects*; D006801:Humans; D008297:Male; D011379:Prognosis; D012480:Salmonella Infections / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome; D014463:Ultrasonography
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone